Cite
Discovery and Evaluation of Enantiopure 9H-pyrimido[4,5-b]indoles as Nanomolar GSK-3β Inhibitors with Improved Metabolic Stability
MLA
Stanislav Andreev, Tatu Pantsar, Ahmed El-Gokha, Francesco Ansideri, Mark Kudolo, Débora Bublitz Anton, Giulia Sita, Jenny Romasco, Christian Geibel, Michael Lämmerhofer, Márcia Ines Goettert, Andrea Tarozzi, Stefan A.Laufer, Pierre Koch. “Discovery and Evaluation of Enantiopure 9H-Pyrimido[4,5-b]Indoles as Nanomolar GSK-3β Inhibitors with Improved Metabolic Stability.” International Journal of Molecular Sciences, Jan. 2020. EBSCOhost, https://doi.org/10.3390/ijms21217823.
APA
Stanislav Andreev, T. P. A. E.-G. F. A. M. K. D. B. A. G. S. J. R. C. G. M. L. M. I. G. A. T. S. A. L. P. K. (2020). Discovery and Evaluation of Enantiopure 9H-pyrimido[4,5-b]indoles as Nanomolar GSK-3β Inhibitors with Improved Metabolic Stability. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21217823
Chicago
Stanislav Andreev, Tatu Pantsar, Ahmed El-Gokha, Francesco Ansideri, Mark Kudolo, Débora Bublitz Anton, Giulia Sita, Jenny Romasco, Christian Geibel, Michael Lämmerhofer, Márcia Ines Goettert, Andrea Tarozzi, Stefan A. Laufer, Pierre Koch. 2020. “Discovery and Evaluation of Enantiopure 9H-Pyrimido[4,5-b]Indoles as Nanomolar GSK-3β Inhibitors with Improved Metabolic Stability.” International Journal of Molecular Sciences, January. doi:10.3390/ijms21217823.